(IN BRIEF) Merck and Siemens have signed a new Memorandum of Understanding that expands their collaboration in life sciences and focuses on accelerating digital transformation across drug discovery, development, and manufacturing. The partnership integrates Merck’s life science SaaS tools and … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, Germany, Healthcare, Management, Pharma & Biotech, Science, Technology
Tagged AI, automation, biomanufacturing, Cedrik Neike, data management, digital innovation, digitalization, Dotmatics, drug development, drug discovery, Expanded Merck-Siemens partnership targets connected digital workflows to accelerate scientific discovery and production, Jean-Charles Wirth, life sciences, Luma, Merck, SaaS, scientific progress, Siemens, Siemens and Merck strengthen alliance with new MoU to advance automation AI and digitalization in life sciences, Siemens Xcelerator, smart manufacturing
(IN BRIEF) Merck has officially opened its first fully climate-neutral manufacturing facility in Cork, Ireland, with a €150 million investment that will create more than 200 jobs by 2028. The 3,000-square-meter site will produce advanced filtration devices essential for the … Read the full press release
Posted in Business, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Ireland, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged aseptic processing, Blarney Business Park, Carrigtwohill, cell therapies, climate-neutral manufacturing, CO2 reduction, Cork, filtration devices, gene therapies, Ireland, Jean-Charles Wirth, Life Science, Merck, Merck invests €150 million in Cork to launch first climate-neutral filter production site and create 200 jobs, Merck strengthens European supply resilience with new climate-neutral manufacturing hub in Cork, monoclonal antibodies, partnership, renewable electricity, SHAPE 2040 strategy, sustainability, tangential-flow filtration, vaccines, virus filtration, €150 million investment, €2 billion global expansion, €440 million Ireland investment
(IN BRIEF) Merck and The Michael J. Fox Foundation (MJFF) are collaborating to advance Parkinson’s disease research using Merck’s SMCxPRO® immunoassay technology. This initiative aims to detect biomarkers indicating cell dysfunction in PD patients, enhancing research into new treatment options … Read the full press release
Posted in Business, Education, Environment, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Innovative Biomarker Technology, Jean-Charles Wirth, Merck, Michael J. Fox Foundation, Nicole Polinski, Parkinson's Research, partnership, SMCxPRO® immunoassay technology, sustainability
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?